CannTab Therapeutics featured on the Midas Letter <span style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" data-mce-type="bookmark" class="mce_SELRES_start"></span> By Republic SuperStar Updated: September 27, 2018 Category: News & Events FSD Pharma Receives First Delivery of Cantabb Equipment with a Capacity to Manufacture Approx. 1,500,000 Tablets Per Day Richard Goldstein joined Steve Darling from Proactive Investors on Skype to share news about their non-binding letter of intent with NewCanna SAS of Bogota, Colombia
